AT-527 550 mg + midazolam
AT-03A-009
Phase 1 small_molecule completed
Quick answer
AT-527 550 mg + midazolam for Healthy Volunteer Study is a Phase 1 program (small_molecule) at Atea Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Atea Pharmaceuticals
- Indication
- Healthy Volunteer Study
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed